Answers are grounded in this paper and cite their sources.
Objectives: Definissse™ core + lidocaine (DEFCL) volumizer is a cross-linked high G’ hyaluronic acid (HA) filler that restores midface volume. The previous studies have documented its effects and tolerability up to 12 months after injection. This 18-month analysis aimed to establish the long-term tolerability and clinical effects of DEFCL volumizer in treating midface volume loss in middle-aged women. Material and Methods: This paper continues the previously published analyses of the prospective and single-center study documenting HA safety and effects after 12 months. Adverse events and injection site reactions were monitored throughout the study. Outcomes were assessed using the Global Aesthetic Improvement Scale, facial volume loss scale, and various skin measurements. Descriptive statistics were provided for all time points. A paired t -test was used to assess outcomes, the Shapiro-Wilk test was done to determine the Gaussian distribution assumption of each outcome, and in case of rejection, a Wilcoxon signed-rank test was applied. Results: All adverse reactions were addressed post-trial, and satisfaction ratings for injectors and patients remained high. Analysis showed ongoing volumization, enhanced skin quality and thickness after 18 months. Conclusion: DEF CL provided sustained volumization, enhanced skin quality, and high satisfaction ratings at 18 months. Further research is warranted on the observed long-term volume-enhancing effects of DEF CL . It is advisable to investigate DEF CL ’s influence on tissue reorganization and remodeling to ensure safety at the molecular level.
No takes yet. Share an insight, caveat, or question.
Salti et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: